Welcome to the News You Might Have Missed, a weekly roundup of news items to help you catch up and stay informed.
It was a busy week with lots of news, have a look and see you next week for another update.
Filament Health Files 20th Patent Application Including Three International PCT Applications
The company announced that it has filed its 20th patent application in support of the Company’s research phase programs. These filings include three international Patent Cooperation Treaty (PCT) patent applications. Read more
MINDCURE Announces Financial Results for Fiscal 2021
The company announced its financial results for the three and twelve months ended May 31, 2021. Read more
The company announced that it has completed another export of the Company’s freshly harvested high-grade psilocybe truffles in bulk quantity, from the Netherlands to Canada, under a Health Canada psilocybin import permit. Read more
PsyBio Therapeutics Reports Second Quarter 2021 Financial Results
The company announced its financial results and business highlights for Q2 2021. Read more
MindMed and BioXcel Therapeutics Publish an International Patent Application
The disclosure provides a method for measuring the signs of an impending agitation event and alerts the caregiver to treat the subject before agitation symptoms arise. Read more
Field Trip Health Ltd. Announces Launch Of “Kap Co-Operative” Program
The KAP Co-op program gives eligible therapists the ability to provide ketamine-assisted psychotherapy (KAP) to their patients at Field Trip Health Centers. Read more
Cybin Announces Additional Adelia Milestone Achievements
Cybin is pleased to announce that Adelia Therapeutics Inc. (“Adelia”), a wholly-controlled subsidiary of Cybin, has achieved certain milestones for Year 1 Q3. Read more
Mindset’s next generation 5-MeO-DMT drug candidates have shown a significant decrease in serotonergic toxicity; results reaffirm superior efficacy and safety. Read more